Volume 5: Issue 1

“Ten years ago physicians treating pulmonary hypertension would have been amazed at today’s options for managing a disease that had a dismal prognosis. Progress has been swift, and we stand at the threshold of a new era in treatment. As our treatment options for pulmonary hypertension have expanded dramatically, so has our need for more information to keep pace with major advances.”

The scientific program of the Pulmonary Hypertension Association is guided by the association’s Scientific Leadership Council. The Council includes the following health care professionals:

Robyn J. Barst, MD, SLC Chair, Columbia Presbyterian Medical Center Babies Hospital, New York, New York
David B. Badesch, MD, SLC Vice-Chair Chair, Nominations Committeee, University of Colorado Health Sciences Center, Denver, Colorado
Raymond L. Benza, MD, University of Alabama, Birmingham, Alabama
Todd Bull, MD, University of Colorado Health Sciences Center, Denver, Colorado
Richard N. Channick, MD, UCSD Medical Center, San Diego, California
Ramona Doyle, MD, Vera M. Wall Center

This discussion was moderated by James P. Maloney, MD, Associate Professor, Division of Pulmonary Science and Critical Care Medicine, University of Colorado, Denver, Colorado. The participants included Robert P. Frantz, MD, Assistant Professor of Medicine, Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota; Michael A. Mathier, MD, Assistant Professor of Medicine, Director, Pulmonary Hypertension Program, and Associate Director, Cardiovascular Fellowship Program, University of Pittsburgh, Pittsburgh, Pennsylvania; and James B. Young, MD, Professor and Chairman, Division of Medicine, and George and Linda Kaufman Chair, Cleveland Clinic Foundation, Cleveland, Ohio.

Chronicling the Evolution of a Journal: We Welcome New Support to Meet Growing Educational Needs of Physicians

The Scientific Leadershp Council of the Pulmonary Hypertension Association

Errata

Jack Reeves, MD, Remembered as “Renaissance Ideal,” in Stellar Career Spanning Diverse Pulmonary Research

Diagnostic Dilemmas: Diastolic Heart Failure Causing Pulmonary Hypertension and Pulmonary Hypertension Causing Diastolic Dysfunction

Pulmonary Hypertension Out of Proportion to Left Heart Disease

Pulmonary Hypertension in Heart Failure Patients Who Are Referred for Cardiac Transplantation

Epidemiology

Controversies and Consensus in PH With Left Heart Disease: Dosing Issues, Transplant Considerations, Wedge Pressure Targets, Postop Drug Selection, and More

Conference Abstracts

Guest Editor’s Memo

A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension

Editor’s Memo

Pulmonary Hypertension Associated With Parenchymal Lung Disease